MFN.se

2026-10-24 09:00:00 BioInvent International BioInvent's BI-1808 and KEYTRUDA® Induce Durable Responses in Heavily Pretreated Platinum-Resistant Ovarian Cancer

2026-10-24 09:00:00 BioInvent International BioInvents BI-1808 och KEYTRUDA® ger varaktiga responser hos kraftigt förbehandlade patienter med platinaresistent äggstockscancer

2026-10-23 18:45:00 Linjemontage Exercise of overallotment option and end of stabilisation period

2026-10-23 18:45:00 Linjemontage Utnyttjande av övertilldelningsoption och avslutande av stabiliseringsperiod

2026-10-23 18:20:00 Dormy Meddelande om stabiliseringsåtgärder, utnyttjande av övertilldelningsoptionen och avslutande av stabiliseringsperioden 70,40 SEK | +0,57% | 1,64 MSEK

2026-10-23 18:00:00 Verkkokauppa.com Verkkokauppa.com Oyj:n omien osakkeiden hankinta viikolla 43/2026

2026-10-23 18:00:00 Verkkokauppa.com Verkkokauppa.com Oyj: Acquisition of own shares during week 43, 2026

2026-10-23 18:00:00 Samhällsbyggnadsbolaget i Norden AB SBB intends to convene a new Extraordinary General Meeting regarding the repurchase and redemption of its Class D shares

2026-10-23 18:00:00 Samhällsbyggnadsbolaget i Norden AB SBB avser att kalla till ny extra bolagsstämma gällande återköp och inlösen av D-aktierna

2026-10-23 18:00:00 Flerie AB The merger between Flerie and Biosergen has been completed

2026-10-23 18:00:00 Flerie AB Fusionen mellan Flerie och Biosergen är slutförd

2026-10-23 17:53:00 TapTravel Nordic AB (publ) TAPTRAVEL INITIATES WRITTEN PROCEDURES UNDER ITS BONDS IN CONNECTION WITH A PROPOSED NEW SHARE ISSUE OF AT LEAST SEK 50 MILLION (SWE)

2026-10-23 17:53:00 TapTravel Nordic AB (publ) TAPTRAVEL INITIATES WRITTEN PROCEDURES UNDER ITS BONDS IN CONNECTION WITH A PROPOSED NEW SHARE ISSUE OF AT LEAST SEK 50 MILLION

2026-10-23 17:42:00 DNB Carnegie Access Scanfil: Strong quarter and improved visibility – Q3 review

2026-10-23 17:30:00 Lamor Kutsu Lamor Corporation Oyj:n ylimääräiseen yhtiökokoukseen

2026-10-23 17:30:00 Lamor Bond Kutsu Lamor Corporation Oyj:n ylimääräiseen yhtiökokoukseen

2026-10-23 17:30:00 Lamor Bond Notice to convene Lamor Corporation Plc's Extraordinary General Meeting of Shareholders

2026-10-23 17:30:00 Lamor Notice to convene Lamor Corporation Plc's Extraordinary General Meeting of Shareholders

2026-10-23 17:20:00 Kalqyl K-Fast Holding: VD-intervju med Jacob Karlsson om Q3'26

2026-10-23 16:45:00 DNB Carnegie Access Micro Systemation: Strong momentum, multiple growth drivers – Q3 review

2026-10-23 16:42:00 Redeye Biovica: Rights issue outcome announced

2026-10-23 16:40:00 Vuxen Group AB (publ) Report from the Annual General Meeting of Vuxen Group AB held on 23 October 2026 27,00 SEK | +2,66% | 0,20 MSEK

2026-10-23 16:40:00 Vuxen Group AB (publ) Kommuniké från årsstämman i Vuxen Group AB den 23 oktober 2026 27,00 SEK | +2,66% | 0,20 MSEK

2026-10-23 16:30:00 Kalqyl Goobit: VD-intervju med Gustav Buder i samband med företrädesemissionen

2026-10-23 15:51:00 DNB Carnegie Access Spago Nanomedical: Move to go private

2026-10-23 15:35:00 Redeye Annexin (Q3 Review): Fully recruited study

2026-10-23 15:30:00 Lamor Bond Sisäpiiritieto: Lamor harkitsee suunnattua osakeantia rahoitusehtojensa mukaisesti ja maksuvalmiuden vahvistamiseksi; neuvottelee rahoittajien kanssa rahoituskovenanttien muutoksista ja poikkeuksista

2026-10-23 15:30:00 Lamor Bond Inside information: Lamor contemplates a directed share issue under its financing arrangements and to strengthen liquidity; negotiates financial covenant reset and waivers with financing providers

2026-10-23 15:30:00 Lamor Sisäpiiritieto: Lamor harkitsee suunnattua osakeantia rahoitusehtojensa mukaisesti ja maksuvalmiuden vahvistamiseksi; neuvottelee rahoittajien kanssa rahoituskovenanttien muutoksista ja poikkeuksista 0,73 EUR | -6,41% | 0,01 MEUR

2026-10-23 15:30:00 Lamor Inside information: Lamor contemplates a directed share issue under its financing arrangements and to strengthen liquidity; negotiates financial covenant reset and waivers with financing providers 0,73 EUR | -6,41% | 0,01 MEUR

2026-10-23 15:30:00 Salmon Evolution Salmon Evolution ASA: Invitation to presentation of Q3 2026 financial results 3,10 NOK | -1,12% | 2,66 MNOK

2026-10-23 14:49:00 Redeye Nanologica: New CEO, updated strategy and SEK110.5m rights issue

2026-10-23 14:48:00 Redeye ExpreS2ion Biotech: Phase I fully enrolled, readout in Q1 2027

2026-10-23 14:47:00 Redeye SSH (Q3 Preview): A Soft Quarter Expected, Focus on Order Timing

2026-10-23 14:37:00 DNB Carnegie Access Ependion: All-time high EBITA – Q3 initial

2026-10-23 14:30:00 Bufab Bufab’s Nomination Committee appointed for the Annual General Meeting 2027 132,60 SEK | -2,93% | 22,7 MSEK

2026-10-23 14:30:00 Bufab Bufabs valberedning inför årsstämman 2027 utsedd 132,60 SEK | -2,93% | 22,7 MSEK

2026-10-23 14:21:00 Redeye Alligator Bioscience (Q3 Review): Partnering Mitazalimab to Fund HLX22

2026-10-23 14:20:00 Redeye BONESUPPORT (Q3 Review): A compelling setup for 2027

2026-10-23 14:19:00 Redeye Xvivo Perfusion (Q3 Review): Heart opportunity approaching

2026-10-23 14:18:00 Redeye Enea (Q3 Review): Cheap, waiting for growth

2026-10-23 14:17:00 Redeye Vitrolife (Q3 review): Technologies leads the way

2026-10-23 14:16:00 Redeye Hexatronic (Q3 Review): Strong quarter all over, with Data Center in the lead

2026-10-23 14:00:00 Modular Finance IR Consensus Electrolux Professional Group – Consensus estimates Q3 2026

2026-10-23 14:00:00 Doxa KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I DOXA AB (PUBL) 0,40 SEK | -1,36% | 0,56 MSEK

2026-10-23 13:35:00 Samhällsbyggnadsbolaget i Norden AB SBB meddelar att tillträdesvillkoren för transaktionen med PPI om 1,35 mdkr har uppfyllts 2,60 SEK | -0,19% | 62,5 MSEK

2026-10-23 13:35:00 Samhällsbyggnadsbolaget i Norden AB SBB announces that the closing conditions for the SEK 1.35 billion transaction with PPI have been satisfied 2,60 SEK | -0,19% | 62,5 MSEK

2026-10-23 13:30:00 OEM International Extra bolagsstämma i OEM International AB (publ) 23 oktober 2026 168,80 SEK | +1,69% | 14,7 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode